Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-LegColor-CodedDopplerUltrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis A Randomized.

Slides:



Advertisements
Similar presentations
Brian M. Johnson, MD CCRMC PBL 11/7/12
Advertisements

VTE Toolkit Chapter Five Venous Disease Coalition
P ULMONARY THROMBOEMBOLISM SPECIFIC SITUATIONS Dr.E.Shabani.
Aggressive Management of Chronic Deep Venous Thrombosis: Technical and Clinical Outcomes Mark J. Garcia M.D. FSIR C Grilli, M McGarry, M Ali, D Agriantonus,
The PERC Rule. The paper Kline et al Journal of Thrombosis and Haemostasis 2008 Prospective Multicenter Evaluation of the Pulmonary Embolism Rule Out.
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Long-Term Outcome After Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (The CaVenT Study):
Venous Thromboembolism
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
The DASH Study Patrick Leonberger MSIV BGSMC Nov 8, 2013.
Peripheral Vascular And Lymphatic Systems
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
How do you approach a patient you think may have a PE?
DVT with ankle fractures: Is thromboprophylaxis warranted? Sunit Patil Jamshid Gandhi Ian Curzon Anthony Hui James Cook University Hospital, Middlesbrough.
Approximately 600,000 new cases are diagnosed in the U.S. each year Thrombus formation in deep veins of legs or thighs Tibial veins, soleal/gastrocnemius.
Deep vein thrombosis. Color duplex scan of DVT Venogram shows DVT.
Unprovoked DVT in a young patient
Thandiwe Murape  Acts as a reservoir to hold blood.  Acts as a conduit to return blood to heart and lungs.  Is composed of single tissue layer.
Lower Extremity Venous Disease: Peripheral Venous Insufficiency
A Comparison of Treatment Options - The Efficacy of Endovenous Laser Ablation and Radiofrequency Ablation Therapy in the Treatment of Symptomatic Venous.
DVT: Symptoms and work-up Sean Stoneking. DVT Epidemilogy Approximately 600,0000 new cases of DVT each year 50% in hospitalized patients or nursing home.
DVT/PE/VTE Adrian Burger 26 April Virchow Triad 3 primary components: venous stasis injury to the intima changes in the coagulation properties of.
EINSTEIN DVT and EINSTEIN PE Pooled Analysis
Epidemiology and diagnosis of acute pulmonary embolism Dr Sam Z Goldhaber Associate Professor of Medicine Harvard Medical School Staff Cardiologist Brigham.
Prospective evaluation of Innovance D-dimer in the exclusion of venous thromboembolism [VTE]. Robert Gosselin, CLS Department of Clinical Pathology and.
1 Lecture 20: Non-experimental studies of interventions Describe the levels of evaluation (structure, process, outcome) and give examples of measures of.
DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group /06/11.
Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011.
H.R. Buller, G. Agnelli Presented at the XXIst Congress of International Society on Thrombosis and Haemostasis (ISTH) 2007 Meeting, July 6-12th in Geneva,
How to Analyze Therapy in the Medical Literature: practical session Akbar Soltani.MD. Tehran University of Medical Sciences (TUMS) Shariati Hospital
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
DVT Protocols The following provides details of Upper and Lower Limb DVT protocols used in our practice. Paige Fabre
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
Jomo Osborne Lung-2015 Baltimore, USA July , 2015.
Chapter Seven Venous Disease Coalition Long-Term Management of VTE VTE Toolkit.
SANOFI-SYNTHELABOARIXTRA ® 1 ARIXTRA ® (fondaparinux sodium) in the prevention of venous thromboembolism after major knee surgery KA Bauer, BI Eriksson,
Duration of Anticoagulation 5 Patients Categories 3. First Episode: 4. First Episode: 5.Recurrent DVT 2. First Episode: 1. First Episode: Transient risk.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Issues in diagnosis of VTE in Pregnancy Ng Heng Joo Department of Haematology Singapore General Hospital.
SANOFI-SYNTHELABOARIXTRA ® 1 ARIXTRA ® (fondaparinux sodium) in the prevention of venous thromboembolism after hip replacement surgery KA Bauer, BI Eriksson,
DEEP VEIN THROMBOSIS (DVT) BY CJ HEYKOOP AND KAYTLYN JORDAN.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Diagnosis of Deep Vein Thrombosis Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis, 9th.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
N ENGL J MED 호흡기내과 R1 윤수진 SCREENING FOR OCCULT CANCER IN UNPROVOKED VENOUS THROMBOEMBOLISM.
Jean‑Jacques Parienti, M.D., Ph.D., Nicolas Mongardon, M.D.,
ACUTE APPENDICITIS IN PREGNANCY : HOW TO MANAGE? HAMRI.A, AARAB.M,NARJIS.Y, RABBANI.K, LOUZI.A,BENELKHAIAT.R, FINECH.B SERVICE DE CHIRURGIE DIGESTIVE MARRAKECH.
Homans Sign: A Sign of What? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism ‘ The PADIS-PE Trial’ Nate Peyton.
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
Date of download: 6/22/2016 From: An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism: A Randomized Trial Ann Intern Med. 2006;144(11):
Pulmonary Embolism in Patients with Unexplained Exacerbation of COPD: Prevalence and Risk Factors Isabelle Tillie-Leblond, MD, PhD; Charles-Hugo Marquette,
Outpatient DVT assessment & treatment Daniel Gilada.
Dep. Of Hemato-Oncology R1. Choi In-Ah D-dimer Testing to Determine the Duration of Anticoagulation Therapy Gualtiero Palareti,M.D., Benilde Cosmi, M.D.,
Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thrombosis Research (2008)
Management of Deep Vein Thrombosis and Pulmonary Embolism by Jack Hirsh, and John Hoak Circulation Volume 93(12): June 15, 1996 Copyright © American.
Presented by Intern邱宏智
the proximal femoral fracture patients
Postoperative Calf Venous Thrombosis: Location, Location, Location
The efficacy and safety of oral Rivaroxaban in patients with permanent inferior vena cava filter: a pilot case-control study Lobastov K., Barinov V.,
New England Society of Interventional Radiology Case Presentation
Evidence Based and Cost Effective Guideline for DVT Triage
Deep vein thrombosis outpatient pathway and ultrasound sensitivity
Simple compression test for DVT
(CMR vs. guidelines, p < 0.001)
Volume 141, Issue 2, Pages e351S-e418S (February 2012)
Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.
Continuous – Wave Doppler
Presentation transcript:

Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-LegColor-CodedDopplerUltrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis A Randomized Controlled Trial JAMA, October 8, 2008—Vol 300, No. 14 호흡기내과 R3 박세정

Compression ultrasonography 1. 2-point ultrasonography (common femoral vein at the groin, popliteal vein at the popliteal fossa) Simplicity (may be proficiently learned in <2 hours), reproducibility, broad availability (may be performed with virtually all ultrasound scanners, irrespective of age, model, and even of the probe frequency) Limitation : need to repeat the test once within 1 week in patients with normal findings at presentation to detect calf DVT extending to the proximal veins (serial 2- point ultrasonography) * repeat testing may be safely avoided in patients with a normal d-dimer test result at presentation

2. whole-leg ultrasonography (color-coded Doppler ultrasound scanners  evaluation of the entire deep venous system, from the groin to the ankle) Advantage : ability to exclude isolated calf DVT, allowing for 1-day treatment of all patients, without additional testing Limitation : needs top-quality ultrasound equipment and experienced operators Prospective, randomized, multicenter study Incidence of symptomatic VTE during a 3-month follow-up period in patients spared anticoagulation on the basis of a normal initial workup with either strategy.

METHODS Patients January 1, 2003, December 21, 2006 Outpatients referred by the ED or primary care physician First episode of suspected symptomatic DVT of thte lower extremities Exclusion : pregnancy, age 48hrs), mandatory indication for anticoagulation (eg, Afib)

METHODS Study Outline Two-Point Strategy : normal US  d-dimer  repeat US at 1wk if abnormal Whole-Leg Strategy Follow-up : normal at initial w/u  f/u visit after 3months (1) interview :general health status, chest or leg complaints, h/o hospital adm (2) P/Ex (3) ultrasonographic evaluation

METHODS Interventions

METHODS Interventions

RESULTS Patients Initial Prevalence of DVT

RESULTS Three-Month Follow-up

CONCLUSION Both serial 2-point ultrasonography plus D-dimer and whole-leg color-coded Doppler ultrasonography represent reliable diagnostic options for the management of symptomatic patients with suspected DVT of the lower extremities. Either strategy may be chosen based on the clinical context, on the patients’ needs, and on the available resources. 2-point US is simple, convenient, and widely available but requires repeat testing in one-fourth of the patients. Whole-leg doppler US offers a 1-day answer, desirable for patients with severe calf complaints, for travelers, and for those living far from the diagnostic service, but is cumbersome, possibly more expensive, and may expose patients to the risk of (unnecessary) anticoagulation.